Good morning! Trump's attorney general nominee went before the Senate, Meta loses a lawyer over its masculinity era, and an at-home test for cervical cancer gets closer to market.
- Take-home test. In a Fortune piece about 20 innovative breakthroughs in health to watch for in 2025, my colleague Erika Fry included Teal Health. The company has indeed achieved a true innovation that is poised to solve one of women's most unpleasant health care experiences: the annual Pap smear, which screens for cervical abnormalities.
Teal Health will allow women to instead screen for cervical cancer at home using a device it calls the "Teal wand." Rather than retrieving cervical cells, Teal's process is a form of primary HPV screening that relies on vaginal cells—which means women can do it themselves. (And because of its form of screening, they only need to do it once every five years.) The company submitted to the FDA in October to offer the first approved at-home cervical cancer screening. It was given a "breakthrough device designation," which means it's on an accelerated path to approval.
